Odyssey Health (ODYY) Cash & Equivalents Growth (5y) (2019 - 2026)
Odyssey Health (ODYY) Cash & Equivalents Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 57.76% |
| Oct 31, 2025 | -38.58% |
| Jul 31, 2025 | -49.06% |
| Apr 30, 2025 | -34.61% |
| Jan 31, 2025 | 21.10% |
| Oct 31, 2024 | -12.04% |
| Jul 31, 2024 | -57.27% |
| Apr 30, 2024 | 188.90% |
| Jan 31, 2024 | 205.05% |
| Oct 31, 2023 | 187.64% |
| Jul 31, 2023 | 148.38% |
| Apr 30, 2023 | -27.46% |
| Jan 31, 2023 | 145.30% |
| Oct 31, 2022 | 34.37% |
| Jul 31, 2022 | 40.13% |
| Apr 30, 2022 | 156.25% |
| Jan 31, 2022 | 74.82% |
| Oct 31, 2021 | 278.06% |
| Jul 31, 2021 | 101.55% |
| Apr 30, 2021 | 147.20% |